Neil and Jason

Artificial intelligence (AI) and machine learning (ML) have the potential to revolutionize drug discovery, but their impact will be limited once we are able to generate more high-quality data. In a recent op-ed, Neil and Jason argue that AI/ML without quality data creates smoke and mirrors.

Click Op-ed in Drug Discovery Online To Read More

Read More